Pay in 4 interest-free payments of $5.63 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Retatrutide, the triple-action GLP-1/GIP/glucagon receptor agonist, outperforms tirzepatide by 23% in the latest human clinical trialthe most comprehensive weight loss comparison to date
Two years after stopping treatment, those who had received higher doses had lower risks of death from any cause
The duration of treatment may extend for several weeks, often continuing until patients reach their desired weight loss goals [11]
If acetic acid water is required, the typical approach is to dissolve the powder fully in a small volume of 0.6% acetic acid water first, then top up with BAC water to your final volume
The formulary, prior authorization criteria, step therapy rules, and appeals all flow through OptumRx
